SecBot SecBot
PRESS-RELEASE ·Filed Nov 16, 2026

IMDX

Insight Molecular Diagnostics Inc.
NEUTRAL
Impact 5/10
Processed5h 31m ago Wirepress-3404180
Press release · Earnings

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3404180

Track record

4 reports on IMDX

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today Press Release Neutral 5/10 Viewing Entry $1.46 Now $1.86 +27.40% settles Feb 16
  2. Nov 16, 2026today Press Release Bearish 5/10 Entry $1.67 Now $1.86 −11.38% settles Feb 16
  3. Aug 10, 202614w ago 8-K Neutral 6/10 Entry $4.43 to $2.65 Now $1.86 −58.01% ▼ −40.18% −39.69% vs SPY
  4. Mar 26, 202633w ago Press Release Bullish 8/10 Entry $3.56 to $5.46 Now $1.86 −47.75% ▲ +53.43% +37.36% vs SPY
Showing 4 of 4

US Market Status

Market Closed · Opens Wed (11h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 16, 2026

Fresh IMDX Intelligence

Analysis is for subscribers only.

Subscribe for Full Access